MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-05-0001148
Rhydburg Pharmaceuticals Ltd - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹48.17 Cr
▲ 26% YoY
Net profit · FY 2024
₹1.42 Cr
Net margin 2.9%
EBITDA · FY 2024
₹3.45 Cr
EBITDA margin 7.2%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.7 Cr
Issued & subscribed
Open charges
₹8.5 Cr
Satisfied ₹39.6 Cr
Company age
39 yrs
Est. 1987
Employees · EPFO
200
Provident fund records
About Rhydburg Pharmaceuticals Ltd
Data last updated:
Rhydburg Pharmaceuticals Ltd is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 June 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1987PLC028434. Its GSTIN is 07AAACR4453M1Z5 (Delhi). The company holds 5 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.7 Cr. It is led by directors including Seema Monga (Whole-Time Director) and Ashok Monga (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B – 9 1st Floor Commercial Complex Dr. Mukharjee Nagar Delhi – 110009, Delhi, India – 110009.
As per the financials filed for FY 2024, the company reported a revenue of ₹48.17 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹1.42 Cr (net margin 2.9%) and EBITDA of ₹3.45 Cr (EBITDA margin 7.2%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 4% over five years.
The company has about 200 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Rhydburg Pharmaceuticals Limited. As per MCA filings, the company has open charges of ₹8.5 Cr and satisfied charges of ₹39.6 Cr on record. Court records list 166 cases involving the company, including 132 filed by the company and 34 filed against it; 28 cases are pending.
Rhydburg Pharmaceuticals Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0001148). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rplglobal.com.
Company details
CIN U24231DL1987PLC028434
Registration Number 028434
Incorporation Date 26 June 1987
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-05-0001148
Recognitions & Rankings of Rhydburg Pharmaceuticals
Contact details
Rhydburg Pharmaceuticals Ltd's registered office is in Delhi, Delhi. Its website is rplglobal.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 9 1st Floor Commercial Complex Dr. Mukharjee Nagar Delhi – 110009, Delhi, India – 110009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rhydburg Pharmaceuticals Ltd, buy the company report.
Comprehensive company report
Rhydburg Pharmaceuticals Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Rhydburg Pharmaceuticals operates one associated brand: Rhydburg Pharmaceuticals Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical exporting, generic medicine supplying, and dosage form manufacturing services. | rplglobal.com |
Business activity
The main business activity of Rhydburg Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rhydburg Pharmaceuticals Ltd, buy the company report.
Financials of Rhydburg Pharmaceuticals Ltd
FY 2024 filings availableRhydburg Pharmaceuticals Ltd reported revenue of ₹48.17 Cr (up 26% YoY) for FY 2024.
Revenue · FY 2024
₹48.17 Cr ▲ 26%
Net profit · FY 2024
₹1.42 Cr margin 2.9%
EBITDA · FY 2024
₹3.45 Cr margin 7.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 2%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 18%
5 years · compounded
▲ 4%
Revenue rose 26% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.45 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.42 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rhydburg Pharmaceuticals Ltd, buy the company report.
Board of directors of Rhydburg Pharmaceuticals Ltd
Rhydburg Pharmaceuticals has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Thapar | Director | 22 Feb 2018 | 8 Years 8 Months | Current |
| Seema Monga Also directs: Dezzle Pharma LLP, Seema Monga's Curls and Curves LLP, Genedrift Solutions LLP and 2 more | Whole-Time Director | 22 Feb 2018 | 8 Years 8 Months | Current |
| Sovan Lal Subalchand Pal Also directs: Inventland Research Laboratories Private Limited | Director | 04 Jun 2025 | 1 Years 4 Months | Current |
| Ashok Monga Also directs: Dezzle Pharma LLP, Seema Monga's Curls and Curves LLP, Genedrift Solutions LLP and 1 more | Whole-Time Director | 15 Dec 1993 | 32 Years 10 Months | Current |
Peer comparison
Rhydburg Pharmaceuticals Ltd is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atoz Pharmaceuticals Private Limited | ₹49.04 Cr (FY 2025) | 20.0% | Ambattur Chenai, Tamil Nadu, India | |||
| Protech Bio Systems Private Limited | ₹48.99 Cr (FY 2025) | -17.0% | New Delhi, Delhi, India | |||
| Montage Laboratories Private Limited | ₹48.49 Cr (FY 2025) | 7.0% | Himatnagar, Gujarat, India | |||
| Sainor Pharma Private Limited | ₹48.47 Cr (FY 2016) | 0.0% | Hyderabad, Telangana, India | |||
| Glow Pharma Private Limited | ₹48.18 Cr (FY 2025) | 23.0% | Mumbai, Maharashtra, India | |||
| Rhydburg Pharmaceuticals Ltdthis company | ₹48.17 Cr (FY 2024) | ₹1.42 Cr | 2.9% | 26.0% | 200 | Delhi, India |
| Edkem Pharmaceuticals Limited | ₹48.11 Cr (FY 2025) | 14.0% | Ahmedabad, Gujarat, India | |||
| Indasi Lifescience Private Limited | ₹48.01 Cr (FY 2025) | 25.0% | Daman, Daman and Diu, India | |||
| R.K. Laboratories Private Limited | ₹47.96 Cr (FY 2024) | 10.0% | Chandigarh, India | |||
| Biddle Sawyer Limited | ₹47.93 Cr (FY 2025) | -28.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Rhydburg Pharmaceuticals Ltd, buy the company report.
Auditor
Rhydburg Pharmaceuticals Ltd is audited by T.K. GUPTA & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T.K. GUPTA & ASSOCIATES | FY 2024 | 011604N |
Shareholding
The shareholding of Rhydburg Pharmaceuticals Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rhydburg Pharmaceuticals Ltd, buy the company report.
Charges & borrowings
Open charges
₹8.5 Cr
Satisfied charges
₹39.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Sep 2019 | 100290129 | Axis Bank Limited | ₹8.5 Cr | Open | |
| 20 Jul 2020 | 100406818 | Axis Bank Limited | ₹45 Lakh | Satisfied | |
| 22 Feb 2018 | 100163421 | Hdfc Bank Limited | ₹9.4 Cr | Satisfied | |
| 02 Jun 2017 | 100102003 | Sidbi | ₹50 Lakh | Satisfied | |
| 29 Jul 2015 | 10584276 | Small Industries Development Bank of India | ₹1 Cr | Satisfied |
To see the full charge records of Rhydburg Pharmaceuticals Ltd, buy the company report.
Total charge records: 16 View all charges
Legal cases
Rhydburg Pharmaceuticals Ltd has 166 court cases on record: 132 filed by Rhydburg Pharmaceuticals, 34 filed against it. 28 cases are pending and 138 are disposed.
Total cases
166
Filed by the company
132
Filed against the company
34
Pending
28
Disposed
138
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 136 | 23 | 19 |
| High courts | 28 | 11 | 9 |
| Supreme Court | 1 | 0 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 166)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Vip Pharmaceuticals Private Limited | Pending |
| District court, Dehradun, Uttarakhand | Criminal case | Filed by the company against Amixor Pharmaceuticals Pvt Ltd. | Pending |
| District court, Dehradun, Uttarakhand | Criminal case | Filed by the company against Addom Pharmaceuticals Pvt Ltd. | Pending |
| District court, South West, Delhi | Criminal case | Filed by the company against Hygieia Biogenics Pvt. Ltd. | Pending |
| District court, Dehradun, Uttarakhand | Criminal case | Filed by the company against Cerotic Healthcare Pvt Ltd and Others and 2 others | Disposed |
To see the full case history of Rhydburg Pharmaceuticals Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Rhydburg Pharmaceuticals Ltd has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 9 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aash Logistics Private Limited | |||
| Alutech Packaging Private Limited | |||
| an individual supplier | |||
| Standard Analytical Laboratory N D Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Rhydburg Pharmaceuticals Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Rhydburg Pharmaceuticals Ltd has a workforce of 200 employees on its EPFO records as of Mar 21, 2025, across 1 active EPFO establishment.
Employee count
200
Active EPFO establishments
1
Employee growth
6.38%
GST
Rhydburg Pharmaceuticals has 5 GST registrations: 2 active and 3 cancelled or inactive.
Total GSTINs
5
Active
2
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACR4453M1Z5 | Delhi | Active | 01 Jul 2017 |
| 05AAACR4453M1Z9 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rhydburg Pharmaceuticals Ltd, buy the company report.
Recent activity
Rhydburg Pharmaceuticals Ltd has 11 board changes on record since 1993: 4 appointments and 7 cessations. The latest: Sovan Lal Subalchand Pal was appointed as Director on 04 Jun 2025.
Appointed
Sovan Lal Subalchand Pal was appointed as Director.
AGM
Rhydburg Pharmaceuticals Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Rhydburg Pharmaceuticals Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge registered on 20 Jul 2020 via Charge ID 100406818 with Axis Bank Limited was fully satisfied on 18 Oct 2022.
Charges
A charge registered on 11 Jun 2013 via Charge ID 10439697 with State Bank Of India was fully satisfied on 27 Oct 2021.
Charges
A charge registered on 22 Feb 2008 via Charge ID 10094516 with State Bank Of India was fully satisfied on 27 Oct 2021.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.45 Cr with Charge ID 100406818 was registered on 20 Jul 2020.
Charges
A charge with Axis Bank Limited of Rs. 8.50 Cr registered on 04 Sep 2019 with Charge ID 100290129 was modified on 15 Jan 2020.
Charges
A charge with Axis Bank Limited amounted to Rs. 8.50 Cr with Charge ID 100290129 was registered on 04 Sep 2019.
Charges
A charge registered on 02 Jun 2017 via Charge ID 100102003 with Sidbi was fully satisfied on 22 Jul 2019.
Charges
A charge registered on 29 Jul 2015 via Charge ID 10584276 with Small Industries Development Bank Of India was fully satisfied on 22 Jul 2019.
Charges
A charge registered on 01 Jul 2013 via Charge ID 10437768 with Small Industries Development Bank Of India was fully satisfied on 22 Jul 2019.
37 earlier events are in the company report.
Frequently asked questions
Rhydburg Pharmaceuticals is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 June 1987 (39+ years old) and is registered under CIN U24231DL1987PLC028434.
Rhydburg Pharmaceuticals has 4 current directors:
- Seema Monga - Whole-Time Director
- Ashok Monga - Whole-Time Director
- Vinod Thapar - Director
- Sovan Lal Subalchand Pal - Director
The latest financial statements of Rhydburg Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Rhydburg Pharmaceuticals is 07AAACR4453M1Z5, registered in Delhi. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 05AAACR4453M1Z9 (Uttarakhand).
The CIN (Corporate Identification Number) of Rhydburg Pharmaceuticals is U24231DL1987PLC028434. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rhydburg Pharmaceuticals has 166 court cases on record: 132 filed by the company and 34 filed against it. 28 are pending. Most are in the district courts.
Rhydburg Pharmaceuticals was incorporated on 26 June 1987, making it 39+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rhydburg Pharmaceuticals by revenue are Atoz Pharmaceuticals Private Limited, Protech Bio Systems Private Limited, Montage Laboratories Private Limited, Sainor Pharma Private Limited, Glow Pharma Private Limited and 4 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sovan Lal Subalchand Pal was appointed as Director on 04 Jun 2025. Ashok Monga ceased to be Director on 29 Sep 2018. Akshay Monga ceased to be Additional Director on 26 Feb 2018. Rhydburg Pharmaceuticals has 11 board changes on record in total.
Yes, Rhydburg Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UK-05-0001148).
Rhydburg Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 9 overdue payments to 5 micro and small suppliers. The latest return was filed on 22 May 2019.
Rhydburg Pharmaceuticals can be reached through the website rplglobal.com. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages